Nanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung
Mari Numata,1 Yelena V Grinkova,2 James R Mitchell,1 Hong Wei Chu,1 Stephen G Sligar,2 Dennis R Voelker1 1Department of Medicine, Program in Cell Biology, National Jewish Health, Denver, CO, USA; 2Department of Biochemistry, University of Illinois, Urbana, IL, USA Abstract: There is increasing inter...
Guardado en:
Autores principales: | Numata M, Grinkova YV, Mitchell JR, Chu HW, Sligar SG, Voelker DR |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/35709cc1895d41f49e070609d2ad7167 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
por: Dirk Roymans, et al.
Publicado: (2017) -
Utility of the Global Respiratory Severity Score for predicting the need for respiratory support in infants with respiratory syncytial virus infection.
por: Jun Kubota, et al.
Publicado: (2021) -
Meteorological drivers of respiratory syncytial virus infections in Singapore
por: Sheikh Taslim Ali, et al.
Publicado: (2020) -
CYTOKINE PROFILE IN ADULTS WITH RESPIRATORY SYNCYTIAL VIRAL INFECTION
por: I. A. Klimova, et al.
Publicado: (2018) -
Respiratory Syncytial Virus-Induced Oxidative Stress Leads to an Increase in Labile Zinc Pools in Lung Epithelial Cells
por: Naseem Ahmed Khan, et al.
Publicado: (2020)